Clinical Trial

Bring Your Own Technology (BYOT) Playbook Offers Roadmap for Using Site-Based Tools in Pharma-Sponsored Trials

RealTime eClinical Solutions co-authors industry-first guide for sponsor-site collaboration on technology choice. SAN ANTONIO, Oct. 7, 2025 /PRNewswire/ -- When…

3 months ago

HeartX Cardiovascular Accelerator Announces Seven Startup Companies Selected for the 2025 Program

FAYETTEVILLE, Ark., Oct. 7, 2025 /PRNewswire/ -- HeartX, powered by HealthTech Arkansas and MedAxiom — along with dozens of leading…

3 months ago

Boosting clinical trial success in Alzheimer’s, Parkinson’s and other neurodegenerative diseases, Upcoming Webinar Hosted by Xtalks

In this free webinar, learn how biomarkers and digital tools are improving clinical trials in neurodegenerative diseases. Attendees will understand the…

3 months ago

Hemostemix’s Insider Lead Order of $330,000 Private Placement

Calgary, Alberta--(Newsfile Corp. - October 7, 2025) - Hemostemix (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") is…

3 months ago

Dogwood Therapeutics, Inc. Chief Medical Officer, Dr. Michael Gendreau, to Present an Overview of the Halneuron® Pain Research Program at the 19th Annual Pain Therapeutics Summit

ATLANTA, GEORGIA / ACCESS Newswire / October 7, 2025 / Dogwood Therapeutics, Inc. (Nasdaq:DWTX) (the "Company"), a development-stage biotechnology company…

3 months ago

Medicus Pharma Ltd. to Present at the Family Office Summit in Dubai, UAE

EXECUTIVE CHAIRMAN & CEO OF MEDICUS TO PARTICIPATE IN A PANEL DISCUSSIONThe Summit theme "unlocking the $1 Trillion Wealth transfer…

3 months ago

Parexel Expands Global Site Alliance Program, Delivering 40% Faster Site Activation, 20% Faster Study Start Up Timelines and Four Times More Patient Enrollments Per Site

Parexel’s Site Alliance Program strengthens global partnerships with clinical research sites and reinforces leadership in site engagement excellenceRALEIGH, N.C., Oct.…

3 months ago

GATC Health Announces Launch of Derisq: The Definitive AI Report for Predictive Risk Assessment of Drug Candidates at Fierce Biotech Week 2025

Derisq delivers actionable insights about drug safety, efficacy and off-target risks prior to committing development capitalBOSTON, Oct. 07, 2025 (GLOBE…

3 months ago

Aligos Therapeutics Announces Eight Abstracts Accepted at The Liver Meeting® 2025

Oral presentation will include the full 96-week and post-treatment follow up data from the Phase 1 monotherapy study of ALG-000184SOUTH…

3 months ago